HTFL · Heartflow, Inc.
$48.37
+6.33% last session
End-of-day data · close of 2026-09-11
Market cap
$4B
Enterprise value
$4B
Trailing P/E
—
Forward P/E
-172.1
Dividend yield
—
Beta
—
Avg volume
2M
Employees
1K
Daily Change %
6.33%
5 Days Change
-4.58%
10 Days Change
-7.38%
30 Days Change
57.99%
60 Days Change
74.66%
Month to Day Change
-7.46%
Year to Day Change
60.10%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — HTFL
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-09-09
Latest call per bank · past 12 months
UBS
Neutral$55.00
+20.9% vs priceMorgan Stanley
Equal-Weight$40.00
-12.1% vs priceJP Morgan
Overweight$45.00
-1.1% vs priceWells Fargo
Overweight$39.00
-14.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | UBS | Initiates | Neutral | $0.00 → $55.00 |
| 2026-08-14 | Canaccord Genuity | Maintains | Buy | $37.00 → $45.00 |
| 2026-08-14 | Morgan Stanley | Maintains | Equal-Weight | $35.00 → $40.00 |
| 2026-08-14 | Piper Sandler | Reiterates | Overweight | $38.00 → $45.00 |
| 2026-08-14 | JP Morgan | Maintains | Overweight | $35.00 → $45.00 |
| 2026-08-14 | Wells Fargo | Maintains | Overweight | $37.00 → $39.00 |
| 2026-08-14 | Stifel | Maintains | Buy | $40.00 → $45.00 |
| 2026-07-31 | Baird | Initiates | Outperform | $0.00 → $34.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 65 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 37.9% above the 50-day MA ($35.07).
- Price vs 200-day MA: Trading 59.6% above the 200-day MA ($30.31).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.88) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($50.43).
HTFL Price Chart
Loading chart for HTFL…
Fundamentals
About Heartflow, Inc.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.
More in Health Information Services
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.